These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 11724153)

  • 1. Considerations for distinguishing influenza-like illness from inhalational anthrax.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2001 Nov; 50(44):984-6. PubMed ID: 11724153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. From the Centers for Disease Control and Prevention. Considerations for distinguishing influenza-like illness from inhalational anthrax.
    JAMA; 2001 Nov; 286(20):2537-9. PubMed ID: 11763847
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhalational anthrax due to bioterrorism: would current Centers for Disease Control and Prevention guidelines have identified the 11 patients with inhalational anthrax from October through November 2001?
    Mayer TA; Morrison A; Bersoff-Matcha S; Druckenbrod G; Murphy C; Howell J; Hanfling D; Cates R; Pauze D; Earls J
    Clin Infect Dis; 2003 May; 36(10):1275-83. PubMed ID: 12746773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Update: investigation of bioterrorism-related inhalational anthrax--Connecticut, 2001.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2001 Nov; 50(47):1049-51. PubMed ID: 11808925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update: Investigation of bioterrorism-related anthrax and interim guidelines for clinical evaluation of persons with possible anthrax.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2001 Nov; 50(43):941-8. PubMed ID: 11708591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update: Investigation of bioterrorism-related anthrax--Connecticut, 2001.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2001 Dec; 50(48):1077-9. PubMed ID: 11770501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinguishing influenza-like illness from inhalational anthrax.
    Lovell RD
    ED Manag; 2002 Jan; 14(1):suppl 2. PubMed ID: 11883060
    [No Abstract]   [Full Text] [Related]  

  • 8. No evidence of a mild form of inhalational Bacillus anthracis infection during a bioterrorism-related inhalational anthrax outbreak in Washington, D.C., in 2001.
    Baggett HC; Rhodes JC; Fridkin SK; Quinn CP; Hageman JC; Friedman CR; Dykewicz CA; Semenova VA; Romero-Steiner S; Elie CM; Jernigan JA
    Clin Infect Dis; 2005 Oct; 41(7):991-7. PubMed ID: 16142664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Update: Investigation of anthrax associated with intentional exposure and interim public health guidelines, October 2001.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2001 Oct; 50(41):889-93. PubMed ID: 11686472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentiating inhalational anthrax from other influenza-like illnesses in the setting of a national or regional anthrax outbreak.
    Cinti SK; Saravolatz L; Nafziger D; Sunstrum J; Blackburn G
    Arch Intern Med; 2004 Mar; 164(6):674-6. PubMed ID: 15037498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fatal case of inhalational anthrax mimicking intra-abdominal sepsis.
    Quintiliani R; Quintiliani R
    Conn Med; 2002 May; 66(5):261-7. PubMed ID: 12071107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical predictors of bioterrorism-related inhalational anthrax.
    Kyriacou DN; Stein AC; Yarnold PR; Courtney DM; Nelson RR; Noskin GA; Handler JA; Frerichs RR
    Lancet; 2004 Jul 31-Aug 6; 364(9432):449-52. PubMed ID: 15288744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. More on anthrax exposure case report.
    McFee RB; Howell JT
    J Am Osteopath Assoc; 2002 Jul; 102(7):362-3; author reply 363-4. PubMed ID: 12138949
    [No Abstract]   [Full Text] [Related]  

  • 14. Recognition and management of anthrax--an update.
    Swartz MN
    N Engl J Med; 2001 Nov; 345(22):1621-6. PubMed ID: 11704686
    [No Abstract]   [Full Text] [Related]  

  • 15. Update: Investigation of bioterrorism-related anthrax and adverse events from antimicrobial prophylaxis.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2001 Nov; 50(44):973-6. PubMed ID: 11724150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical features that discriminate inhalational anthrax from other acute respiratory illnesses.
    Kuehnert MJ; Doyle TJ; Hill HA; Bridges CB; Jernigan JA; Dull PM; Reissman DB; Ashford DA; Jernigan DB
    Clin Infect Dis; 2003 Feb; 36(3):328-36. PubMed ID: 12539075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suspected cutaneous anthrax in a laboratory worker--Texas, 2002.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2002 Apr; 51(13):279-81. PubMed ID: 11952281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influenza review and outlook. 2002-2003, with additional considerations for differentiation from inhalation anthrax.
    Morgan R; Tan C; O'Donnell C; Bresnitz E
    N J Med; 2002 Oct; 99(10):21-6; quiz 26-8. PubMed ID: 12400233
    [No Abstract]   [Full Text] [Related]  

  • 19. Update: Cutaneous anthrax in a laboratory worker--Texas, 2002.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2002 Jun; 51(22):482. PubMed ID: 12064454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Death due to bioterrorism-related inhalational anthrax: report of 2 patients.
    Borio L; Frank D; Mani V; Chiriboga C; Pollanen M; Ripple M; Ali S; DiAngelo C; Lee J; Arden J; Titus J; Fowler D; O'Toole T; Masur H; Bartlett J; Inglesby T
    JAMA; 2001 Nov; 286(20):2554-9. PubMed ID: 11722269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.